Capturing Structure-Activity Relationships from Chemogenomic Spaces

被引:13
|
作者
Wendt, Bernd [1 ]
Uhrig, Ulrike [2 ]
Boes, Fabian [2 ]
机构
[1] European Mol Biol Lab, D-69117 Heidelberg, Germany
[2] Tripos Int, D-81829 Munich, Germany
关键词
TARGET; SIMILARITY; PREDICTION; MOLECULES; PHARMACOLOGY; VALIDATION; SEARCHES; 2D;
D O I
10.1021/ci100270x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Modeling off-target effects is one major goal of chemical biology, particularly in its applications to drug discovery. Here, we describe a new approach that allows the extraction of structure-activity relationships from large chemogenomic spaces starting from a single chemical structure. Several public source databases, offering a vast amount of data on structure and activity for a large number of different targets, have been investigated for their usefulness in automated structure-activity relationships (SAR) extraction. SAR tables were constructed by assembling similar structures around each query structure that have an activity record for a particular target. Quantitative series enrichment analysis (QSEA) was applied to these SAR tables to identify trends and to transform these trends into topomer CoMFA models. Overall more than 1700 SAR tables with topomer CoMFA models have been obtained from the ChEMBL, Pub Chem, and ChemBank databases. These models were able to highlight the structural trends associated with various off-target effects of marketed drugs, including cases where other structural similarity metrics would not have detected an off-target effect. These results indicate the usefulness of the QSEA approach, particularly whenever applicable with public databases, in providing a new means, beyond a simple similarity between ligand structures, to capture SAR trends and thereby contribute to success in drug discovery.
引用
收藏
页码:843 / 851
页数:9
相关论文
共 50 条
  • [41] STRUCTURE-ACTIVITY RELATIONSHIPS FOR BENZYL ALCOHOLS
    TINLAND, B
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1973, 5 (03): : 855 - 857
  • [42] Structure-activity relationships in cell culture
    Wagner, RW
    OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS, 1997, 209 : 142 - 154
  • [43] SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF BACTERIOCINS
    Vederas, J.
    BIOPOLYMERS, 2009, 92 (04) : 303 - 303
  • [44] Structure-Activity Relationships of Daptomycin Lipopeptides
    Karas, John A.
    Carter, Glen P.
    Howden, Benjamin P.
    Turner, Adrianna M.
    Paulin, Olivia K. A.
    Swarbrick, James D.
    Baker, Mark A.
    Li, Jian
    Velkov, Tony
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (22) : 13266 - 13290
  • [45] STRUCTURE-ACTIVITY RELATIONSHIPS IN APHOLATE ANALOGS
    CASTLE, RE
    RISTICH, SS
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1966, 14 (03) : 301 - +
  • [46] Structure-activity relationships of the avermectins and milbemycins
    Fisher, MH
    PHYTOCHEMICALS FOR PEST CONTROL, 1997, 658 : 220 - 238
  • [47] STRUCTURE-ACTIVITY RELATIONSHIPS IN BRADYKININ ANALOGUES
    STEWART, JM
    FEDERATION PROCEEDINGS, 1968, 27 (01) : 63 - &
  • [48] SOME STRUCTURE-ACTIVITY RELATIONSHIPS IN PHENOTHIAZINES
    GORDON, M
    TEDESCHI, RE
    COOK, L
    TEDESCHI, DH
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1963, 13 (04): : 318 - &
  • [49] Structure-Activity Relationships of the Enterococcal Cytolysin
    Rahman, Imran R.
    Sanchez, Alondra
    Tang, Weixin
    van der Donk, Wilfred A.
    ACS INFECTIOUS DISEASES, 2021, 7 (08): : 2445 - 2454
  • [50] Structure-Activity Relationships of Polymyxin Antibiotics
    Velkov, Tony
    Thompson, Philip E.
    Nation, Roger L.
    Li, Jian
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (05) : 1898 - 1916